EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Living Therapeutics for Synergistic Hydrogen‐Photothermal Cancer Treatment by Photosynthetic Bacteria

Yingyi Zhang, Xiaolian Deng, Lili Xia, Jianghui Liang, Meng Chen, Xiaoling Xu, Wei Chen, Jianwei Ding, Chengjie Yu, Limei Liu, Yang Xiang, Yiliang Lin und 4 weitere

Advanced Science · 2025-01 · 12 (1)

DOI: 10.1002/advs.202408807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 04.11.2024. Verfasst von Yingyi Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China. Hauptthemen laut MEDLINE: Hydrogen, Rhodobacter sphaeroides, Photothermal Therapy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Shenzhen Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydrogen gas (H 2 ) therapy, recognized for its inherent biosafety, holds significant promise as an anti‐cancer strategy. However, the efficacy of H 2 treatment modalities is compromised by their reliance on systemic gas administration or chemical reactions generation, which suffers from low efficiency, poor targeting, and suboptimal utilization. In this study, living therapeutics are employed using photosynthetic bacteria Rhodobacter sphaeroides for in situ H 2 production combined with near‐infrared (NIR) mediated photothermal therapy. Living R. sphaeroides exhibits strong absorption in the NIR spectrum, effectively converting light energy into thermal energy while concurrently generating H 2 . This dual functionality facilitates the targeted induction of tumor cell death and substantially reduces collateral damage to adjacent normal tissues. The findings reveal that integrating hydrogen therapy with photothermal effects, mediated through photosynthetic bacteria, provides a robust, dual‐modality approach that enhances the overall efficacy of tumor treatments. This living therapeutic strategy not only leverages the therapeutic potential of both hydrogen and photothermal therapeutic modalities but also protects healthy tissues, marking a significant advancement in cancer therapy techniques.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogenRhodobacter sphaeroidesPhotothermal TherapyMiceAnimalsNeoplasmsHumansPhotosynthesisDisease Models, AnimalCell Line, Tumor

Stichwörter der Autor:innen

hydrogen therapyhydrogen‐photothermal therapyliving bacterial therapiesphotosynthetic bacteria

Substanzen

Hydrogen

Autor:innen und Institutionen

  • Department of Pharmacology, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
  • Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academic of Science, Shenzhen, 518000, P. R. China.
  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
  • Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, 310016, P. R. China.
  • Key laboratory for accurate diagnosis and treatment of abdominal infection in Zhejiang province, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, 310016, P. R. China.
  • Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, 117585, Singapore.

ORCID-Profile: Yu Chen

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Shenzhen Science and Technology Program
  • Shanghai Science and Technology Committee Biomedical Program
  • Guangdong Basic and Applied Basic Research Foundation
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, Y., Deng, X., Xia, L., Liang, J., Chen, M., Xu, X., Chen, W., Ding, J., Yu, C., Liu, L., Xiang, Y., Lin, Y., Duan, F., Feng, W., Chen, Y., & Gao, X. (2025). Living Therapeutics for Synergistic Hydrogen‐Photothermal Cancer Treatment by Photosynthetic Bacteria. Advanced Science, 12(1). https://doi.org/10.1002/advs.202408807

Vancouver

Zhang Y, Deng X, Xia L, Liang J, Chen M, Xu X, et al. Living Therapeutics for Synergistic Hydrogen‐Photothermal Cancer Treatment by Photosynthetic Bacteria. Advanced Science. 2025;12(1). doi:10.1002/advs.202408807

BibTeX
@article{Zhang2025,
  author = {Zhang, Yingyi and Deng, Xiaolian and Xia, Lili and Liang, Jianghui and Chen, Meng and Xu, Xiaoling and Chen, Wei and Ding, Jianwei and Yu, Chengjie and Liu, Limei and Xiang, Yang and Lin, Yiliang and Duan, Fangfang and Feng, Wei and Chen, Yu and Gao, Xiang},
  title = {Living Therapeutics for Synergistic Hydrogen‐Photothermal Cancer Treatment by Photosynthetic Bacteria},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {1},
  doi = {10.1002/advs.202408807}
}
Kostenlos starten →